The IAAE Life Sciences Advisory Board
Who is the IAAE®?
A not for profit, education and credentialing organization, focused on building workforce capability in Life Sciences digital manufacturing.
Why was the IAAE Life Sciences Advisory Board formed?
To support an ecosystem of likeminded individuals and companies with a desire to see the industry improve as a whole and who can share needs and inform the strategy of the organization, solving a problem (workforce development and capability building) too big for any one company or partner to solve alone.
Who is currently represented on the LSAB?
There are currently thirteen Pharma/BioPharma companies represented.
What is the history and purpose of the LSAB?
The advisory board was formed in 2017 and has met every 2-3 months since then with a quarter-to-quarter focus. The purpose of the IAAE® is to mobilize humanity towards a new economy with the vision of equipping the workforce (as well as students and job-seekers) to innovate the future of digital manufacturing in the Life Sciences.
What is our ask of those who join the LSAB?
We would ask for your virtual attendance (between 1-2 hours) at five meetings in the year, with one optional in-person meeting.
We would also ask for your participation (2-3 hours between March and May on a sub-committee of your choosing.
Why IAAE?
IAAE seeks to credential 10,000 learners globally, and to engage 10 of the top 20 companies in each regulated health industry, by the end of 2035.
Current IAAE Life Sciences Advisory Board logos shown
Why does the IAAE have an advisory board and what role does it play?
Our Life Sciences Advisory Board, plays a crucial role in guiding IAAE's work. The board identifies key capabilities required to support digital manufacturing objectives and collaborates on several initiatives each through subgroups. Their industry expertise ensures that our educational offerings remain aligned with the needs of medical product and device manufacturers, and informed by the trends they are experiencing, with the outcome of ultimately helping them navigate the challenges posed by evolving technologies and regulatory requirements.
Adam Lynch
Sr. Manager Packaging Engineering, Maintenance & Automation
Adam currently works as Sr. Manager of Engineering, Maintenance, and Automation at Amgen Ohio in New Albany, O
Alan Bledsoe
Associate Director - Global Process Automation and Control Engineering
Experienced engineering director with over 20 years in the Pharmaceutical and Medical Device industry, delivering high quality, reliable, and technical solutions.
Dan Hill
Director, Senior Product, Cross Divisional Program Integration
Dan is a senior digital leader and Process Analytical Technology (PAT) expert with extensive experience developing and executing global digital transformation strategies, within and across CMC and R&D organizations. Passionate about enabling seamless operations and high productivity through digital application and employee up-skilling.
Daniel Carraher
Head of Digital and Data Science – Takeda Global Manufacturing and Supply (GMS) Massachusetts
Daniel has several decades of expertise in the pharmaceutical industry, focusing on product and process lifecycle, manufacturing science, data science, and analytics. He is passionate about applying AI and machine learning across all pharmaceutical domains.
Anthony Le Marre
VP Global Head of Manufacturing Systems & Automation
Greg Bischoff
Director, Manufacturing Automation Architecture and Platforms at Merck
Kevin Wu
Associate Director, Automation Control Systems at BMS
Peterjohn Millan
Head of Digital Systems, Automation, and Metrology
Rachelle Howard
Director of Manufacturing Systems Automation and Digital Strategy
Rafael Gilot
Director Automation & Metrology at Sanofi
Tony Farero
Director, HR Business Partner, Global Technology
Andrew Bird
Associate Vice President, Business Technology Manufacturing and Supply
Rob Guenard
Head of Digital Realization at Biogen
Lorem ipsum
